These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19865048

  • 1. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer.
    Yuan K, Qian C, Zheng R.
    Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048
    [Abstract] [Full Text] [Related]

  • 2. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 4. [Retinoid expression (RARbeta and CRBP1) in non-small-cell lung carcinoma].
    Mauro LV, Dalurzo M, Smith D, Lastiri J, Vasallo B, Joffei EB, Pallotta MG, Puricelli L.
    Medicina (B Aires); 2008 Oct 01; 68(3):205-12. PubMed ID: 18689151
    [Abstract] [Full Text] [Related]

  • 5. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer.
    Cooper WA, Kohonen-Corish MR, McCaughan B, Kennedy C, Sutherland RL, Lee CS.
    Histopathology; 2009 Jul 01; 55(1):28-36. PubMed ID: 19614764
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 7. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer.
    Hansen LV, Skov BG, Ploug M, Pappot H.
    Lung Cancer; 2007 Nov 15; 58(2):260-6. PubMed ID: 17706320
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 15; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 9. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
    Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ.
    Cancer Res; 1997 Feb 01; 57(3):433-9. PubMed ID: 9012470
    [Abstract] [Full Text] [Related]

  • 10. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY, Liang XM, Lin SX, Luo RZ, Hou JH, Zhang L.
    Ai Zheng; 2004 Jul 01; 23(7):845-50. PubMed ID: 15248926
    [Abstract] [Full Text] [Related]

  • 11. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K, Pezzella F, Gatter KC, Harris AL.
    Br J Cancer; 2001 Sep 14; 85(6):881-90. PubMed ID: 11556841
    [Abstract] [Full Text] [Related]

  • 12. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Yanagitani N, Sunaga N, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Histopathology; 2009 Jun 14; 54(7):804-13. PubMed ID: 19635099
    [Abstract] [Full Text] [Related]

  • 13. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
    Graziano SL, Tatum AH, Gonchoroff NJ, Newman NB, Kohman LJ.
    Clin Cancer Res; 1997 Jan 14; 3(1):87-93. PubMed ID: 9815542
    [Abstract] [Full Text] [Related]

  • 14. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 14; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 15. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct 14; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 16. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 17. Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.
    Bria E, Visca P, Novelli F, Casini B, Diodoro MG, Perrone-Donnorso R, Botti C, Sperduti I, Facciolo F, Milella M, Cecere FL, Cognetti F, Mottolese M.
    Eur J Surg Oncol; 2008 May 24; 34(5):593-8. PubMed ID: 17693049
    [Abstract] [Full Text] [Related]

  • 18. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G.
    Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326
    [Abstract] [Full Text] [Related]

  • 19. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
    Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Inui K, Oyanagi H, Yamada T, Nakayama J, Fujimoto I, Ikenaka K, Wada H.
    Cancer Res; 2001 Feb 15; 61(4):1666-70. PubMed ID: 11245481
    [Abstract] [Full Text] [Related]

  • 20. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer.
    Albert JM, Gonzalez A, Massion PP, Chen H, Olson SJ, Shyr Y, Diaz R, Lambright ES, Sandler A, Carbone DP, Putnam JB, Johnson DH, Lu B.
    Cancer Epidemiol Biomarkers Prev; 2007 Sep 15; 16(9):1845-51. PubMed ID: 17855704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.